Testimony in favor for SB 669 Tobacco Products - Minimum Age and Civil Fines

Following is testimony given by Emilie Gilde, Director of Tobacco Use and Cardiovascular Disease Prevention. The statement was presented to the Finance Committee on behalf of Dr. Wen on March 9, 2017.

Thank you to the chair and members of the committee.  My name is Emilie Gilde and I am the Director of Tobacco Use and Cardiovascular Disease Prevention at Baltimore City Health Department. I am testifying on behalf of Baltimore City Health Commissioner Dr. Leana Wen in support of Senate Bill 669.

We support SB669 because we believe that raising the minimum age to purchase tobacco products will result in significant decreases in youth tobacco use initiation and prevalence.  Tobacco use is the number one driver of preventable deaths in Baltimore City and is a priority area in Healthy Baltimore 2020, our strategy to reduce health disparities.

As you have heard from other panel members, there is substantial evidence that supports raising the minimum age to purchase tobacco.  Instead of re-iterating these points I want to give examples from the field. My office conducts youth enforcement checks to make sure that youth are not able to purchase tobacco products.  We also proactively offer education to retailers about tobacco laws and how to check for identification.  After these education sessions, we offer a quick assessment to ensure we have been effective.  Retailers pass our assessments with flying colors, except for one question about vertical and horizontal identification, and whether they are able to sell tobacco to kids under 18.  

We need to eliminate this confusion and ensure that all products that are harmful to youth brain development have the same minimum age of 21 years.  By having consistency, we will accomplish significant reductions in tobacco use as well as eliminate confusion for retailers who conduct ID checks.

We urge your favorable support for SB 669. Thank you.

Related Stories

Letter in Support for Teen Pregnancy Prevention Funding

TO:                Senator Chris Van Hollen
FROM:          Dr. Leana Wen, Baltimore City Health Commissioner
RE:                Support for Adolescent Health Education

Dear Senator Van Hollen:

On July 6, 2017, the Baltimore City Health Department (BCHD) received notice from the Department of Health and Human Services’ Office of Adolescent Health (OAH) that the grant period for the U Choose evidence-based program would be shortened by two years, which will reduce the overall funding for this program by $3.5M over two years. This change will result in reduced access to evidence-based teen pregnancy curricula for thousands of students in Baltimore, creating a vacuum of critical health education for thousands of vulnerable teens.

Testimony in favor of SB 868 Prescribing and Dispensing Naloxone to Non-certificate Holders

Following is testimony given by Mark O’Brien, Director of Opioid Overdose Prevention and Treatment. The statement was presented to the Finance Committee on behalf of Dr. Wen on March 16, 2017.

Testimony in favor for HB 909 Maryland Health Insurance Coverage Protection Act

Following is testimony given by Legislative Director Jeff Amoros. The statement was presented to the Health and Government Operations Committee on behalf of Dr. Wen on March 10, 2017.